An international security conference explored how artificial intelligence (AI) technologies for drug discovery could be misused for de novo design of biochemical weapons. A thought experiment evolved into a computational proof.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Scientific Data Open Access 26 July 2023
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Spiez Convergence Conference https://www.spiezlab.admin.ch/en/home/meta/refconvergence.html (2021).
Urbina, F., Lowden, C. T., Culberson, J. C. & Ekins, S. https://doi.org/10.33774/chemrxiv-2021-nlwvs (2021).
Mansouri, K. et al. Environ. Health Perspect. 129, 047013 (2021).
Blaschke, T. et al. J. Chem. Inf. Model. 60, 5918–5922 (2020).
National Research Council Committee on Toxicology. https://www.ncbi.nlm.nih.gov/books/NBK233724/ (National Academies Press, 1997).
Aroniadou-Anderjaska, V., Apland, J. P., Figueiredo, T. H., De Araujo Furtado, M. & Braga, M. F. Neuropharmacology 181, 108298 (2020).
Genheden, S. et al. J. Cheminform. 12, 70 (2020).
Coley, C. W. et al. Science 365, eaax1566 (2019).
Dix, D. J. et al. Toxicol. Sci. 95, 5–12 (2007).
Hutson, M. The New Yorker https://www.newyorker.com/tech/annals-of-technology/who-should-stop-unethical-ai (2021).
Brown, T. B. et al. Preprint at arXiv https://arxiv.org/abs/2005.14165 (2020).
Prunkl, C. E. A. et al. Nat. Mach. Intell. 3, 104–110 (2021).
Organisation for the Prohibition of Chemical Weapons. The Hague Ethical Guidelines https://www.opcw.org/hague-ethical-guidelines (2021).
We are grateful to the organizers and participants of the Spiez Convergence conference 2021 for their feedback and questions. C.I. contributed to this article in his personal capacity. The views expressed in this article are those of the authors only and do not necessarily represent the position or opinion of Spiez Laboratory or the Swiss Government. We kindly acknowledge US National Institutes of Health funding under grant R44GM122196-02A1 from the National Institute of General Medical Sciences and 1R43ES031038-01 and 1R43ES033855-01 from the National Institute of Environmental Health Sciences for our machine learning software development and applications. Research reported in this publication was supported by the National Institute of Environmental Health Sciences of the National Institutes of Health under grants R43ES031038 and 1R43ES033855-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
F.U. and S.E. work for Collaborations Pharmaceuticals, Inc. F.L. and C.I. have no conflicts of interest.
Peer review information
Nature Machine Intelligence thanks Gisbert Schneider and Carina Prunkl for their contribution to the peer review of this work.
About this article
Cite this article
Urbina, F., Lentzos, F., Invernizzi, C. et al. Dual use of artificial-intelligence-powered drug discovery. Nat Mach Intell 4, 189–191 (2022). https://doi.org/10.1038/s42256-022-00465-9
This article is cited by
Nature Reviews Materials (2023)
Scientific Data (2023)
Nature Machine Intelligence (2022)
Nature Machine Intelligence (2022)